Androgen receptor content of the normal and hyperplastic canine prostate.

A procedure was developed for measurement of androgen receptors in cytoplasmic extracts of prostates from intact dogs. The protocol utilized exchange saturation analysis at 15 degrees C employing the synthetic androgen R1881 (17beta-hydroxy-17alpha-methylestra-4,9,11-trien-3-one) as the ligand probe and quantitatively detected total cytoplasmic androgen receptor (R(c), androgen-free receptor, and R(c)A, androgen-occupied receptor) present at the initiation of the assay. This protocol was employed in conjunction with a tissue mince saturation analysis procedure (for quantitation of nuclear androgen receptor) to quantitate total androgen receptor content of normal and hyperplastic prostates obtained from young (2.5- or 4.6-yr old) and aged (12.5-yr old) purebred dogs of known birth date. The total cytoplasmic androgen receptor content (picomoles per prostate) of hyperplastic prostates was 4.6-fold greater than that of normal prostates. The total nuclear androgen receptor content of hyperplastic prostates (picomoles per prostate measured in crude nuclear preparations) was either 5.0- (4.6-yr-old dogs) or 7.8-fold (2.5-yr-old dogs) greater than that of normal prostates. However, androgen receptor content per cell was identical for hyperplastic and normal canine prostates, with the exception that nuclear androgen receptor was diminished in prostates from 2.5-yr-old dogs. The cell content per gram dry weight was identical for hyperplastic and normal canine prostates. We conclude that canine prostate hyperplasia is characterized by coordinate proliferation of androgen receptor-positive and androgen receptor-negative cells and is not a consequence of increased accumulation of 5alpha-dihydrotestosterone due to proliferation of androgen receptors per prostate cell.

[1]  S. Shain,et al.  Aging-associated diminished rat prostate androgen receptor content concurrent with decreased androgen dependence , 1977, Mechanisms of Ageing and Development.

[2]  Jean D. Wilson,et al.  The Formation of 5α-Androstane-3α,17β-diol by Dog Prostate , 1976 .

[3]  C. Bonne,et al.  Assay of androgen binding sites by exchange with methyltrienolone (R 1881) , 1976, Steroids.

[4]  P. Walsh,et al.  The induction of prostatic hypertrophy in the dog with androstanediol. , 1976, The Journal of clinical investigation.

[5]  W. McGuire,et al.  Scatchard plots: Common errors in correction and interpretation , 1975, Steroids.

[6]  S. Shain,et al.  Spontaneous adenocarcinomas of the ventral prostate of aged A X C rats. , 1975, Journal of the National Cancer Institute.

[7]  S. Shain,et al.  Aging in the rat prostate. Reduction in detectable ventral prostate androgen receptor content. , 1975, Archives of biochemistry and biophysics.

[8]  J. Grayhack,et al.  The effect of orchiectomy and estrogens of benign prostatic hyperplasia. , 1972, The Journal of urology.

[9]  J. Wilson,et al.  Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man. , 1970, The Journal of clinical investigation.

[10]  J. Wilson,et al.  Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog. , 1970, The Journal of clinical investigation.

[11]  J. Geller,et al.  TREATMENT OF BENIGN PROSTATIC HYPERTROPHY WITH HYDROXYPROGESTERONE CAPROATE: EFFECT ON CLINICAL SYMPTOMS, MORPHOLOGY, AND ENDOCRINE FUNCTION. , 1965, JAMA.

[12]  O. Berg.  Parenchymatous hypertrophy of the canine prostate gland. , 1958, Acta endocrinologica.

[13]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[14]  W. Scott.  THE PHYSIOLOGY OF THE PROSTATE GLAND , 1945, Bulletin of the Johns Hopkins Hospital.

[15]  C. Huggins.  THE PHYSIOLOGY OF THE PROSTATE GLAND , 1945 .

[16]  P. J. Clark,et al.  QUANTITATIVE STUDIES OF PROSTATIC SECRETION , 1940, The Journal of experimental medicine.

[17]  S. Shain,et al.  Prostate carcinogenesis in the AXC rat. , 1977, Oncology.

[18]  S. Shain,et al.  Identification of limited capacity androgen binding components in nuclear and cytoplasmic fractions of canine prostate. , 1977, Endocrine research communications.

[19]  Jean D. Wilson,et al.  The Formation of 5a-Androstane-3a:,17)8-cliol by Dog Prostate , 1976 .

[20]  F. Gannon,et al.  Current models of steroid hormone action: a critique. , 1976, Annual review of physiology.

[21]  B. O’Malley,et al.  The biology and mechanism of steroid hormone receptor interaction with the eukaryotic nucleus. , 1976, Biochemical pharmacology.

[22]  R. King,et al.  Steroid-cell interactions , 1974 .

[23]  P. Ofner.  Effects and metabolism of hormones in normal and neoplastic prostate tissue. , 1968, Vitamins and hormones.

[24]  PROSTATIC secretion. , 1952, Medical world.